Piotr J Wysocki

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Topics

Prostate Cancer

Prognostic Factors

Top Venues

Journal of clinical medicine

Nature medicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Buda-Nowak, Łukasz Kwinta, Paweł Potocki, Anna Michałowska-Kaczmarczyk, Agnieszka Słowik, Kamil Konopka, Joanna Streb, Maciej Koniewski, Piotr J Wysocki
Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer-A Retrospective Analysis of Consecutive Patients Data. Journal of clinical medicine 12 (4) (2023)
Anna Buda-Nowak, Łukasz Kwinta, Paweł Potocki, Anna Michałowska-Kaczmarczyk, Agnieszka Słowik, Kamil Konopka, Joanna Streb, Maciej Koniewski, Piotr J Wysocki
Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer-A Retrospective Analysis of Consecutive Patients Data. Journal of clinical medicine 12 (4) (2023)
Paweł Michał Potocki, Piotr Wójcik, Łukasz Chmura, Bartłomiej Goc, Marcin Fedewicz, Zofia Bielańska, Swadźba Jakub, Kamil Konopka, Łukasz Kwinta, Piotr J Wysocki
Clinical Characterization of Targetable Mutations (BRAF V600E and KRAS G12C) in Advanced Colorectal Cancer-A Nation-Wide Study. International journal of molecular sciences 24 (10) (2023)
Piotr J Wysocki, Mateusz Łobacz, Paweł Michał Potocki, Łukasz Kwinta, Anna Michałowska-Kaczmarczyk, Agnieszka Słowik, Kamil Konopka, Anna Buda-Nowak
Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer. Cancers 15 (4) (2023)
Paweł Michał Potocki, Rafał Wiśniowski, Dominik Haus, Zbyszko Chowaniec, Maciej Kozaczka, Magdalena Kustra, Marzenna Samborska-Plewicka, Marcin Szweda, Danuta Starzyczny-Słota, Magdalena Michalik, Grzegorz Słomian, Aneta Lebiedzińska, Natalia Jonak-Olczyk, Natalia Łaszewska-Kraińska, Krzysztof Adamowicz, Piotr Kolenda, Anna Drosik-Kwaśniewska, Marek Szwiec, Robert Dziura, Justyna Czech, Maria Blaszkowska, Ewa Nowakowska-Zajdel, Ewa Klank-Sokołowska, Kamil Konopka, Łukasz Kwinta, Jolanta Dobrzańska, Piotr J Wysocki
The Impact of Sidedness on the Efficacy of Anti-EGFR-Based First-Line Chemotherapy in Advanced Colorectal Cancer Patients in Real-Life Setting-A Nation-Wide Retrospective Analysis (RACER). Cancers 15 (17) (2023)
Anna Buda-Nowak, Łukasz Kwinta, Paweł Potocki, Anna Michałowska-Kaczmarczyk, Agnieszka Słowik, Kamil Konopka, Joanna Streb, Maciej Koniewski, Piotr J Wysocki
Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer-A Retrospective Analysis of Consecutive Patients Data. Journal of clinical medicine 12 (4) (2023)
Piotr J Wysocki, Mateusz Łobacz, Paweł Michał Potocki, Łukasz Kwinta, Anna Michałowska-Kaczmarczyk, Agnieszka Słowik, Kamil Konopka, Anna Buda-Nowak
Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer. Cancers 15 (4) (2023)
Piotr J Wysocki, Mateusz Łobacz, Paweł Michał Potocki, Łukasz Kwinta, Anna Michałowska-Kaczmarczyk, Agnieszka Słowik, Kamil Konopka, Anna Buda-Nowak
Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer. Cancers 15 (4) (2023)
Piotr J Wysocki, Maciej T Lubas, Malgorzata L Wysocka
Metronomic Chemotherapy in Prostate Cancer. Journal of clinical medicine 11 (10) (2022)
Kamil Konopka, Paulina Frączek, Maciej Lubaś, Agnieszka M Micek, Łukasz Kwinta, Joanna Streb, Paweł Potocki, Piotr J Wysocki
Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer. Journal of clinical medicine 11 (5) (2022)
Thomas Powles, Kobe C Yuen, Silke Gillessen, Edward E Kadel, Dana Rathkopf, Nobuaki Matsubara, Charles G Drake, Karim Fizazi, Josep M Piulats, Piotr J Wysocki, Gary L Buchschacher, Boris Alekseev, Begoña Mellado, Bogusława Karaszewska, Jennifer F Doss, Grozdana Rasuo, Asim Datye, Sanjeev Mariathasan, Patrick Williams, Christopher J Sweeney
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial. Nature medicine 28 (1) (2022)